6550--Supplies - Blood Bank Reagents 5-Yr OP - Saginaw

The Department of Veterans Affairs issued a five-year indefinite-delivery, indefinite-quantity (IDIQ) contract under solicitation number 36C25026Q0442 for the supply of specialized blood bank reagents, with performance running from May 1, 2026, through April 30, 2031. The contract, awarded on April 28, 2026, is a firm-fixed-price, sole-source procurement for four brand-specific reagents—AFFIRMAGEN, SELECTOGEN, COOMBS CONTROL, and CONFIDENCE—justified under FAR 12.102 due to their unique compatibility with existing laboratory systems. The minimum annual order requirement is 13 units per item, with no maximum quantity specified, and all deliveries are made FOB destination to the VA Medical Center in Saginaw, Michigan. The awardee, QUIDELORTHO SALES COMPANY, LLC, is identified as other than small, with no socioeconomic set-asides applied, and the award was made under the Lowest Price Technically Acceptable (LPTA) methodology. Contract administration is managed by Contracting Officer Kellie Konopinski, with mandatory electronic invoicing via EFT under VAAR 852.232-72 and FAR 52.232-33, and all payments processed through the VA Financial Management System in Austin, Texas. Key clauses include deviations from standard FAR language such as 52.216-22 (Indefinite Quantity), 52.216-19 (Order Limitations with TBD thresholds), and 52.219-1 (Small Business Representations), along with incorporated provisions on trafficking in persons, child labor, and Buy American compliance. The contract includes no packaging or marking specifications, no designated COR/COTR, and requires proposal submissions strictly via email with Standard Form 1449 by the April 14, 2026 deadline. Unit prices are not disclosed in the available documentation, rendering the total contract value undetermined despite the clearly defined ordering period and minimum quantities.